Erik van Duijn

3.6k total citations
73 papers, 2.6k citations indexed

About

Erik van Duijn is a scholar working on Cellular and Molecular Neuroscience, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Erik van Duijn has authored 73 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cellular and Molecular Neuroscience, 35 papers in Neurology and 19 papers in Psychiatry and Mental health. Recurrent topics in Erik van Duijn's work include Genetic Neurodegenerative Diseases (56 papers), Neurological disorders and treatments (32 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (14 papers). Erik van Duijn is often cited by papers focused on Genetic Neurodegenerative Diseases (56 papers), Neurological disorders and treatments (32 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (14 papers). Erik van Duijn collaborates with scholars based in Netherlands, United Kingdom and Germany. Erik van Duijn's co-authors include Rose C. van der Mast, Erik J. Giltay, Raymund A.C. Roos, Anna A.M. Hubers, David Craufurd, G. Bernhard Landwehrmeyer, Karen E. Anderson, Reinier Timman, Hugh Rickards and Maria Dale and has published in prestigious journals such as PLoS ONE, The British Journal of Psychiatry and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Erik van Duijn

70 papers receiving 2.5k citations

Peers

Erik van Duijn

CMN

NEURO

PMH

Raphael M. Bonelli Austria

Glen Wunderlich Canada

Hugh Rickards United Kingdom

Luc Mallet France

Katie Kompoliti United States

Berta Pascual‐Sedano Spain

Mateusz Zurowski Canada

Chiara Cerami Italy

Joaquim Alves da Silva Portugal

J.L. Waddington Ireland

Raphael M. Bonelli Austria

Erik van Duijn

962 ×0.6

CMN

869 ×0.6

NEURO

465 ×0.6

372 ×0.7

PMH

359 ×1.0

Citations per year, relative to Erik van Duijn Erik van Duijn (= 1×) peers Raphael M. Bonelli

Countries citing papers authored by Erik van Duijn

Since Specialization

Citations

This map shows the geographic impact of Erik van Duijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik van Duijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik van Duijn more than expected).

Fields of papers citing papers by Erik van Duijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik van Duijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik van Duijn. The network helps show where Erik van Duijn may publish in the future.

Co-authorship network of co-authors of Erik van Duijn

This figure shows the co-authorship network connecting the top 25 collaborators of Erik van Duijn. A scholar is included among the top collaborators of Erik van Duijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik van Duijn. Erik van Duijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meijer, Eline, Erik van Duijn, Susanne T. de Bot, et al.. (2024). Development of the Huntington Support App (HD-eHelp study): a human-centered and co-design approach. Frontiers in Neurology. 15. 1399126–1399126.

Duijn, Erik van, et al.. (2023). Palliative care in advanced Huntington’s disease: a scoping review. BMC Palliative Care. 22(1). 54–54. 2 indexed citations

Duijn, Erik van, et al.. (2021). Incidence of completed suicide and suicide attempts in a global prospective study of Huntington's disease. BJPsych Open. 7(5). e158–e158. 10 indexed citations

Oosterloo, Mayke, et al.. (2019). Obsessive-Compulsive and Perseverative Behaviors in Huntington’s Disease. Journal of Huntington s Disease. 8(1). 1–7. 29 indexed citations

Anderson, Karen E., Erik van Duijn, David Craufurd, et al.. (2018). Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders. Journal of Huntington s Disease. 7(4). 355–366. 65 indexed citations

Gelderblom, Hans, Torsten Wüstenberg, Wilhelm Fischer, et al.. (2017). Bupropion for the treatment of apathy in Huntington’s disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial. PLoS ONE. 12(3). e0173872–e0173872. 43 indexed citations

Škorvánek, Matěj, Jennifer G. Goldman, Marjan Jahanshahi, et al.. (2017). Global scales for cognitive screening in Parkinson's disease: Critique and recommendations. Movement Disorders. 33(2). 208–218. 152 indexed citations

Duijn, Erik van. (2017). Medical treatment of behavioral manifestations of Huntington disease. Handbook of clinical neurology. 144. 129–139. 11 indexed citations

Pool, René, Eleni Mina, Kristina Hettne, et al.. (2016). Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington’s disease peripheral blood samples. Metabolomics. 12(8). 137–137. 41 indexed citations

10.

Beurs, Edwin de, et al.. (2015). Comparing Methods to Denote Treatment Outcome in Clinical Research and Benchmarking Mental Health Care. Clinical Psychology & Psychotherapy. 23(4). 308–318. 26 indexed citations

11.

Beurs, Derek de, Judith E. Bosmans, Marieke H. de Groot, et al.. (2015). Training mental health professionals in suicide practice guideline adherence: Cost-effectiveness analysis alongside a randomized controlled trial. Journal of Affective Disorders. 186. 203–210. 15 indexed citations

12.

Duijn, Erik van, David Craufurd, Anna A.M. Hubers, et al.. (2014). Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY). Journal of Neurology Neurosurgery & Psychiatry. 85(12). 1411–1418. 205 indexed citations

13.

Beurs, Derek de, Marieke H. de Groot, Jos de Keijser, et al.. (2013). Improving the application of a practice guideline for the assessment and treatment of suicidal behavior by training the full staff of psychiatric departments via an e-learning supported Train-the-Trainer program: study protocol for a randomized controlled trial. Trials. 14(1). 9–9. 16 indexed citations

14.

Hubers, Anna A.M., Erik van Duijn, Raymund A.C. Roos, et al.. (2013). Suicidal ideation in a European Huntington's disease population. Journal of Affective Disorders. 151(1). 248–258. 65 indexed citations

15.

Hubers, Anna A.M., et al.. (2011). Suicidality in Huntington's disease. Journal of Affective Disorders. 136(3). 550–557. 48 indexed citations

16.

Duijn, Erik van, et al.. (2011). Adverse childhood experiences of persons at risk for Huntington's disease or BRCA1/2 hereditary breast/ovarian cancer. Clinical Genetics. 81(1). 18–23. 36 indexed citations

17.

Duijn, Erik van. (2010). Treatment of Irritability in Huntington’s Disease. Current Treatment Options in Neurology. 12(5). 424–433. 24 indexed citations

18.

Duijn, Erik van, Erik J. Giltay, Frans G. Zitman, et al.. (2010). Hypothalamic–pituitary–adrenal axis functioning in Huntington's disease mutation carriers compared with mutation-negative first-degree controls. Brain Research Bulletin. 83(5). 232–237. 36 indexed citations

19.

Duijn, Erik van, et al.. (2010). Correlates of Apathy in Huntington’s Disease. Journal of Neuropsychiatry. 22(3). 287–294. 45 indexed citations

20.

Duijn, Erik van, et al.. (2007). Psychopathology in Verified Huntington’s Disease Gene Carriers. Journal of Neuropsychiatry. 19(4). 441–448. 229 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact